Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | US

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Recordati Industria Chimica e Farmaceutica Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.	Italy	REC
RECURSION PHARMACEUTICALS, INC. AI-driven biotech accelerating drug discovery for rare diseases and oncology.	United States of America	RXRX
RedHill Biopharma Ltd. Develops oral drugs for GI, infectious diseases, and pandemic preparedness.	United States of America	RDHL
Regencell Bioscience Holdings Ltd Develops TCM-based therapies for neurocognitive disorders like ADHD and ASD.	United States of America	RGC
REGENERON PHARMACEUTICALS, INC. A biotech firm inventing, developing, and commercializing medicines for serious diseases.	United States of America	REGN
REGENXBIO Inc. Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.	United States of America	RGNX
Rein Therapeutics, Inc. Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.	United States of America	RNTX
Rekah Pharmaceutical Prod Ltd. A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.	Israel	REKA
Relay Therapeutics, Inc. Developing precision medicines for oncology & genetic diseases by analyzing protein motion.	United States of America	RLAY
Repare Therapeutics Inc. Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.	United States of America	RPTX